MetaADEDB 2.0 @ LMMD
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
(JWNPDZNEKVCWMY-VQHVLOKHSA-N)
Structure
SMILES
CCOc1cc2ncc(c(c2cc1NC(=O)/C=C/CN(C)C)Nc1ccc(c(c1)Cl)OCc1ccccn1)C#N
Type(s)
Approved; Investigational
ATC code(s)
L01XE45
Molecular Formula:
C30H29ClN6O3
Molecular Weight:
557.043
Log P:
6.0785
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
112.4
CAS Number(s):
698387-09-6; 876310-02-0
Synonym(s)
1.
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
2.
HKI 272
3.
HKI-272
4.
HKI272
5.
neratinib
External Link(s)
MeSHC487932
PubChem Compound9915743
BindingDB50161957
ChEBI61397
CHEMBLCHEMBL180022
DrugBankDB11828
DrugCentral5252
IUPHAR/BPS Guide to PHARMACOLOGY5686
KEGGdr:D08950
Therapeutic Target DatabaseD0Q9CY
ZINC3916214
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 167US FAERS
2FatigueFAERS: 155US FAERS
3VomitingFAERS: 78US FAERS
4ConstipationFAERS: 70US FAERS
5Abdominal PainFAERS: 44US FAERS
6Drug dose omissionFAERS: 42US FAERS
7HeadacheFAERS: 31US FAERS
8Abdominal discomfortFAERS: 27US FAERS
9DizzinessFAERS: 27US FAERS
10DehydrationFAERS: 26US FAERS
11DyspepsiaFAERS: 22US FAERS
12Weight decreasedFAERS: 20US FAERS
13MalaiseFAERS: 15US FAERS
14AcneFAERS: 13US FAERS
15AstheniaFAERS: 12US FAERS
16StomatitisFAERS: 12US FAERS
17ArthralgiaFAERS: 11US FAERS
18Dry skinFAERS: 11US FAERS
19Blood potassium decreasedFAERS: 10US FAERS
20DysgeusiaFAERS: 10US FAERS
21Incorrect dose administeredFAERS: 10US FAERS
22PainFAERS: 9US FAERS
23Urinary tract infectionFAERS: 8US FAERS
24SomnolenceFAERS: 7US FAERS
25Drug administration errorFAERS: 6US FAERS
26Feeling abnormalFAERS: 6US FAERS
27MyalgiaFAERS: 6US FAERS
28NasopharyngitisFAERS: 6US FAERS
29Peripheral swellingFAERS: 6US FAERS
30Acute kidney injuryFAERS: 5US FAERS
31ErythemaFAERS: 5US FAERS
32FlatulenceFAERS: 5US FAERS
33Gastrointestinal sounds abnormalFAERS: 5US FAERS
34HypotensionFAERS: 5US FAERS
35Product dose omissionFAERS: 5US FAERS
36White blood cell count decreasedFAERS: 5US FAERS
37Back PainFAERS: 4US FAERS
38OnychoclasisFAERS: 4US FAERS
39AlopeciaFAERS: 3US FAERS
40AnxietyFAERS: 3US FAERS
41Dermatitis acneiformFAERS: 3US FAERS
42Drug ineffectiveFAERS: 3US FAERS
43EpistaxisFAERS: 3US FAERS
44EructationFAERS: 3US FAERS
45Hospice CareFAERS: 3US FAERS
46Intentional dose omissionFAERS: 3US FAERS
47Oropharyngeal painFAERS: 3US FAERS
48Prescribed underdoseFAERS: 3US FAERS
49PruritusFAERS: 3US FAERS
50ThirstFAERS: 3US FAERS
51TremorFAERS: 3US FAERS
52Abdominal tendernessFAERS: 2US FAERS
53Alanine Aminotransferase IncreasedFAERS: 2US FAERS
54Bladder spasmFAERS: 2US FAERS
55Blood creatinine increasedFAERS: 2US FAERS
56Bone painFAERS: 2US FAERS
57Burning sensationFAERS: 2US FAERS
58ChillsFAERS: 2US FAERS
59Disease ProgressionFAERS: 2US FAERS
60DysphemiaFAERS: 2US FAERS
61DysphoniaFAERS: 2US FAERS
62DysuriaFAERS: 2US FAERS
63Early satietyFAERS: 2US FAERS
64Escherichia sepsisFAERS: 2US FAERS
65Escherichia urinary tract infectionFAERS: 2US FAERS
66GastritisFAERS: 2US FAERS
67HypersensitivityFAERS: 2US FAERS
68InfectionFAERS: 2US FAERS
69OnychalgiaFAERS: 2US FAERS
70PancreatitisFAERS: 2US FAERS
71Productive CoughFAERS: 2US FAERS
72SneezingFAERS: 2US FAERS
73Therapy changeFAERS: 2US FAERS
74Urinary tract discomfortFAERS: 2US FAERS
75Visual ImpairmentFAERS: 2US FAERS
76Accidental overdoseFAERS: 1US FAERS
77AmnesiaFAERS: 1US FAERS
78Anal inflammationFAERS: 1US FAERS
79Animal biteFAERS: 1US FAERS
80Apparent life threatening eventFAERS: 1US FAERS
81ArthritisFAERS: 1US FAERS
82Blood glucose decreasedFAERS: 1US FAERS
83Blood iron decreasedFAERS: 1US FAERS
84BronchitisFAERS: 1US FAERS
85Chest PainFAERS: 1US FAERS
86Chest discomfortFAERS: 1US FAERS
87ChromaturiaFAERS: 1US FAERS
88Chronic Fatigue SyndromeFAERS: 1US FAERS
89Clostridium difficile infectionFAERS: 1US FAERS
90ColitisFAERS: 1US FAERS
91ConjunctivitisFAERS: 1US FAERS
92Critical IllnessFAERS: 1US FAERS
93CystitisFAERS: 1US FAERS
94Depressed moodFAERS: 1US FAERS
95DiscomfortFAERS: 1US FAERS
96Drug administered to patient of inappropriate ageFAERS: 1US FAERS
97EcchymosisFAERS: 1US FAERS
98Electrolyte imbalanceFAERS: 1US FAERS
99Emergency CareFAERS: 1US FAERS
100Eye irritationFAERS: 1US FAERS
101Feeling jitteryFAERS: 1US FAERS
102FlushingFAERS: 1US FAERS
103Food PoisoningFAERS: 1US FAERS
104GastroenteritisFAERS: 1US FAERS
105Gastrointestinal perforationFAERS: 1US FAERS
106GoutFAERS: 1US FAERS
107Hair growth rate abnormalFAERS: 1US FAERS
108HepatitisFAERS: 1US FAERS
109HordeolumFAERS: 1US FAERS
110Impaired driving abilityFAERS: 1US FAERS
111Inappropriate schedule of drug administrationFAERS: 1US FAERS
112InfluenzaFAERS: 1US FAERS
113Infrequent bowel movementsFAERS: 1US FAERS
114Intentional product use issueFAERS: 1US FAERS
115Joint swellingFAERS: 1US FAERS
116Lip swellingFAERS: 1US FAERS
117Lower respiratory tract infectionFAERS: 1US FAERS
118Mental impairmentFAERS: 1US FAERS
119Metastatic NeoplasmFAERS: 1US FAERS
120Mood swingsFAERS: 1US FAERS
121Mouth swellingFAERS: 1US FAERS
122Musculoskeletal chest painFAERS: 1US FAERS
123Neck PainFAERS: 1US FAERS
124Negative thoughtsFAERS: 1US FAERS
125NervousnessFAERS: 1US FAERS
126NeutropeniaFAERS: 1US FAERS
127Oral painFAERS: 1US FAERS
128PapuleFAERS: 1US FAERS
129Paranasal sinus hyposecretionFAERS: 1US FAERS
130PharyngitisFAERS: 1US FAERS
131Physical disabilityFAERS: 1US FAERS
132PneumoniaFAERS: 1US FAERS
133Post procedural infectionFAERS: 1US FAERS
134Product packaging quantity issueFAERS: 1US FAERS
135Rash erythematousFAERS: 1US FAERS
136Recall phenomenonFAERS: 1US FAERS
137RetchingFAERS: 1US FAERS
138Rubber sensitivityFAERS: 1US FAERS
139Saliva alteredFAERS: 1US FAERS
140Sjogren's SyndromeFAERS: 1US FAERS
141Slow speechFAERS: 1US FAERS
142Sputum retentionFAERS: 1US FAERS
143SyncopeFAERS: 1US FAERS
144Therapy cessationFAERS: 1US FAERS
145ThrombosisFAERS: 1US FAERS
146Tongue erythemaFAERS: 1US FAERS
147Upper-airway cough syndromeFAERS: 1US FAERS
148UrticariaFAERS: 1US FAERS
149VertigoFAERS: 1US FAERS
150Vulvovaginal burning sensationFAERS: 1US FAERS
151Vulvovaginal painFAERS: 1US FAERS
152Vulvovaginal pruritusFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.